China Resources Sanjiu Medical & Pharmaceutical Co Ltd Class A 000999
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 63.88
- Day Range
- CNY 62.88–64.44
- 52-Week Range
- CNY 40.52–68.80
- Bid/Ask
- CNY 63.55 / CNY 63.56
- Market Cap
- CNY 62.80 Bil
- Volume/Avg
- 4.8 Mil / 6.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 21.26
- Price/Sales
- 2.44
- Dividend Yield (Trailing)
- 1.57%
- Dividend Yield (Forward)
- 1.57%
- Total Yield
- 1.57%
Company Profile
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 20,318
- Website
- http://www.999.com.cn
Comparables
Valuation
|
Metric
|
000999
|
600267
|
600380
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.26 | 203.81 | 17.48 |
Price/Book Value | 3.10 | 1.27 | 1.70 |
Price/Sales | 2.44 | 0.97 | 1.49 |
Price/Cash Flow | 13.40 | 6.46 | 5.28 |
Price/Earnings
000999
600267
600380
Financial Strength
|
Metric
|
000999
|
600267
|
600380
|
|---|---|---|---|
Quick Ratio | 1.26 | 0.55 | — |
Current Ratio | 1.74 | 0.88 | — |
Interest Coverage | 46.15 | 0.39 | — |
Quick Ratio
000999
600267
600380
Profitability
|
Metric
|
000999
|
600267
|
600380
|
|---|---|---|---|
Return on Assets (Normalized) | 9.22% | −0.67% | — |
Return on Equity (Normalized) | 19.32% | −1.46% | — |
Return on Invested Capital (Normalized) | 13.57% | 0.27% | — |
Return on Assets
000999
600267
600380
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Njtnwlxgg | Cqcq | $79.1 Bil | |
MKKGY
| Merck KGaA ADR | Klgphttf | Xnnkksj | $74.3 Bil | |
HLN
| Haleon PLC ADR | Zzxycmd | Rnkjb | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Gphfhjyy | Nkl | $19.1 Bil | |
VTRS
| Viatris Inc | Lvmzfngg | Rbbk | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tlmsnvsfn | Jpz | $11.7 Bil | |
CTLT
| Catalent Inc | Ltskrmkvd | Xwprjb | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Mfrqlbfbq | Rtfp | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Pnwqlzff | Qpj | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Cdtgdxlkk | Qtwzsm | $3.3 Bil |